Publicaciones (63) Publicaciones en las que ha participado algún/a investigador/a


  1. 5-HT 2 receptor binding, functional activity and selectivity in N-benzyltryptamines

    PLoS ONE, Vol. 14, Núm. 1

  2. 2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 16, pp. 3551-3558

  3. A New Model of Sensorial Neuron-Like Cells for HTS of Novel Analgesics for Neuropathic Pain

    SLAS Discovery, Vol. 24, Núm. 2, pp. 158-168

  4. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

  5. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs

    International Journal of Pharmaceutics, Vol. 565, pp. 151-161

  6. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population

    International Journal of COPD, Vol. 14, pp. 371-380

  7. Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

    Journal of Arrhythmia, Vol. 35, Núm. 1, pp. 18-24

  8. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

  9. Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production

    Free Radical Research, Vol. 53, Núm. 2, pp. 150-169

  10. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting

    Journal of Chemotherapy, Vol. 31, Núm. 1, pp. 49-57

  11. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  12. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment

    Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715

  13. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients

    International Journal of Pharmaceutics, Vol. 567

  14. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates Neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro

    Molecular Pharmaceutics, Vol. 16, Núm. 4, pp. 1456-1466

  15. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells

    Journal of Controlled Release, Vol. 295, pp. 60-73

  16. Conciliación de la medicación en el paciente crítico

    Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 19, pp. 63-69

  17. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: An exploratory study

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 3, pp. 124-128

  18. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  19. Design of polymeric nanocapsules to improve their lympho-targeting capacity

    Nanomedicine, Vol. 14, Núm. 23, pp. 3013-3033

  20. Devising of a risk map on the management of high risk alert medication in a high level university hospital

    Farmacia Hospitalaria, Vol. 43, Núm. 3, pp. 110-115